F

First Wave BioPharma, Inc.

14 employees

First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
chronic pancreatitis
niclosamide
Wellness
Lipase
exocrine pancreatic insufficiency
Recombinant proteins
Non-sytemic therapies
Health Care
cystic fibrosis
immune checkpoint inhibitor colitis
Medical
pancreatic enzyme replacement therapy
COVID-19 GI infections

Date founded

2014

Funding rounds raised

Total raised

$2.6M

from 1 investors over 1 rounds

F

First Wave BioPharma, Inc. raised $2.6M on September 6, 2018

Investors: Omega Funds

FAQ